Trial Profile
Takepron Capsules 15/ Orally Dispersing (OD) Tablets 15 Special Drug Use Surveillance Long-term Use Survey on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Low-dose Aspirin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2022
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications NSAID-induced ulcer
- Focus Adverse reactions
- Sponsors Takeda
- 04 Apr 2014 New trial record